Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood vaccines remained below prepandemic levels.

Gavi, which helps countries purchase and distribute vaccines, is among thousands of programs determined to be "inconsistent ...

RNA vaccines are composed of the nucleic acid RNA, which encode antigen genes of an infectious agent. When administered to host cells, the RNA is translated into protein antigens that elicit ...

$1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a crucial component of the more than $12 ...

That rises to 92.1% after 14 days when you've had one dose but are still waiting for the other. Correspondence in The New England Journal of Medicine (NEJM) states that antibodies produced in response ...

Since licensure in 2006, the rotavirus vaccines, RV5 (pentavalent bovine-human ... increased risk of intussusception after the first 1 or 2 doses has slowly emerged, with the risk benefit equation ...

Rotavirus was discovered in 1973, and 10 years later the first report of a rotavirus vaccine clinical trial appeared. This update reviews the epidemiology of rotavirus infections, assesses past ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

With the virus spreading rapidly around the world, the need for a vaccine was desperate — but the prior record for the fastest development of a new vaccine to a new virus was four years.

The $1 billion facility is the product of a broader investment ... in a statement. Merck sells a number of vaccines, including Gardasil, which protects against human papillomavirus, as well as shots ...

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid ...